Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
about
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort studyBeyond BMI: The "Metabolically healthy obese" phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic reviewNonalcoholic fatty liver disease as a multi-systemic diseaseVascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and FerritinNAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?Current Management of NAFLDRelationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?Almanac 2015: atrial fibrillation research in HeartResearch advances in the relationship between nonalcoholic fatty liver disease and atherosclerosisThe Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment StrategyGenetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and SteatohepatitisAssociation of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-AnalysisExercise for hepatic fat accumulation in type 2 diabetic subjectsNon-alcoholic fatty liver disease: what has changed in the treatment since the beginning?Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver diseaseRecent advances in the diagnosis and management of cirrhosis-associated cardiomyopathy in liver transplant candidates: advanced echo imaging, cardiac biomarkers, and advanced heart failure therapiesStudying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiologyCardiovascular dysfunction in patients with liver cirrhosisRole of cardiovascular intervention as a bridge to liver transplantationLipid-lowering agents in the management of nonalcoholic fatty liver diseaseHepatic steatosis and Type 2 diabetes: current and future treatment considerations.Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.Acute kidney injury and post-reperfusion syndrome in liver transplantationNonalcoholic fatty liver disease - A multisystem disease?Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic TargetsFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVLow-normal thyroid function and novel cardiometabolic biomarkersManagement of moderate to severe psoriasis in patients with metabolic comorbiditiesCoordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primatesRole of β-adrenergic receptors in regulation of hepatic fat accumulation during agingPancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver diseaseNon-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease.Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence: findings from a cross-sectional study.
P2860
Q24596256-0455E639-1916-41AE-BA72-823974F298C6Q24618259-F09C8E0C-0ED8-450C-AB85-2756746DFC50Q26749290-65AD3ECB-BCA0-4B14-9CB3-C671A749324EQ26750865-60EBA30C-8EF4-4248-853D-149326387FCAQ26750955-9930BE3B-E944-4E7C-9BFA-8F7F2B6728CAQ26752729-8A6B1FBD-679D-4088-B3AF-CC2EC14CF0B4Q26767276-68049CA3-8B40-4D6C-8100-C2F69AD85B7FQ26770598-B7A4CDF3-9299-4CF5-85BF-348C11FFA4C7Q26775340-2DD96C7F-7B16-4A13-9F08-31358B403C85Q26780509-F4B913BC-D833-40A3-8E7B-A4BF4E2AF169Q26781753-52B91F87-218C-445E-95D2-042C83D265CCQ26798151-F4927864-20F5-4278-BF74-41BD25256ABDQ26798155-0838D2F7-2F0F-4540-8052-B40A4BBC4AB3Q26827764-57C70138-BA56-433B-9D32-5D4241BEEE5BQ26829503-490E52B3-86E0-45A8-98B7-43656CA214F9Q26853645-D5E0575D-DE3B-434B-9BCA-65EA5BD7AE52Q27002436-F0094FFE-1F1E-4AF4-8061-736550FD0DC7Q27010291-9B4E75EC-CBDF-4F7D-A7B0-33DA85585CE2Q27010592-13676EC6-1BA2-4C99-BA31-1B72B2DB99F4Q27011341-1036BA7D-3E0C-401A-92D2-C07BAE0C52A2Q27024352-FFED1BC7-0134-495F-BB60-86354A32CE31Q27691399-10CE6622-468A-493A-95AF-C8F0A4B8D366Q27692035-79379CE9-1048-4232-9699-9FBF005B7FD6Q28074228-497D22B9-4C26-49D8-81B1-E53E35E8BE68Q28079077-3C28B7BC-94B9-4A24-B3A1-4B9F0534D21BQ28079713-63EB5E69-2680-453F-B259-A7A104284786Q28079826-5FCD8BEC-9C36-41B1-ADFF-DC3294A01D97Q28084990-C146EDC9-74B8-4644-8728-39BA2251DEC6Q28087039-C9C32449-C6BA-4FFF-94B2-5B37A1833ABBQ28478084-DDC4D266-0BBB-4E89-B444-21F5B72A7FFCQ28572834-A754D26D-C2CD-413F-A5AA-9AFCA6DD6749Q28649518-35E419E8-0315-4485-99D8-E5A9BAB291AAQ30235846-D90DECC8-D8EB-4F5D-8976-62C3C6B483D3Q30244335-10E59B5F-3A5F-492F-9DDB-D9AC0A5435B6Q30360538-73B154EB-B85E-4849-A28D-E6FE27A53EA6Q30364476-1BAE5911-F8B1-4D18-862C-53CC44BB60E6Q30382172-2ABA0E9A-229C-4A93-8CF4-900DE31E265BQ30389752-60F432E9-6773-4690-87FF-F2A227CDFDFEQ30401022-AAA07BE7-2602-4536-A041-6677C74758D3Q30418630-865AF983-9B74-4538-9F00-6AD8D1C6F6D2
P2860
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
@en
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
@nl
type
label
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
@en
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
@nl
prefLabel
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
@en
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
@nl
P2093
P356
P1476
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
@en
P2093
Christopher P Day
Enzo Bonora
Giovanni Targher
P304
P356
10.1056/NEJMRA0912063
P407
P577
2010-09-01T00:00:00Z